ADAKVEO (crizanlizumab-tmca) injection. FDA approved

FDA approved Anti-Cancer medicine ADAKVEO (crizanlizumab-tmca) injection is available upon request. To get best retail price of ADAKVEO (crizanlizumab-tmca) injection in India, For emergency product orders call 8750295029 (Mr. Neeraj Nagpal) or For enquires email info@medvitaz.com For advanced treatments in India, Medvitaz Pharma Solution can even help patient to discuss with hematologist-oncologist.
Category: .

ADAKVEO (crizanlizumab-tmca) injection, for intravenous use. Initial U.S. Approval: 2019

INDICATIONS AND USAGE
ADAKVEO is a selectin blocker indicated to reduce the frequency of vasoocclusive crises in adults and pediatric patients aged 16 years and older with sickle cell disease

DOSAGE FORMS & STRENGTHS
Injection: 100 mg/10 mL (10 mg/mL) solution in a single-dose vial.
Manufactured By: Novartis Pharmaceuticals Corporation
Prescribing Information URL: Click Here

HOW TO MAKE AN ENQUIRY FOR ADAKVEO (crizanlizumab-tmca) injection?

FDA approved Anti-Cancer medicine ADAKVEO (crizanlizumab-tmca) injection is available upon request. To get best retail price of ADAKVEO (crizanlizumab-tmca) injection in India, For emergency product orders call 8750295029 (Mr. Neeraj Nagpal) or For enquires email info@medvitaz.com For advanced treatments in India, Medvitaz Pharma Solution can even help patient to discuss with hematologist-oncologist.

Crizanlizumab, sold under the brand name Adakveo, is a monoclonal antibody medication developed by Novartis targeted towards P-selectin. It was announced by the company as an effective drug to prevent vaso-occlusive crisis in patients with sickle cell anemia. The result of the Phase II SUSTAIN clinical trial was published in December 2016. Crizanlizumab is a treatment to reduce the frequency of vaso-occlusive crisis – a common and painful complication of sickle cell disease that occurs when blood circulation is obstructed by sickled red blood cells – for those 16 years and older.

In November 2019, crizanlizumab-tmca was approved in the United States. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication.

How and where to buy crizanlizumab-tmca injection?

You can order crizanlizumab-tmca injection through Medvitaz Pharma Solutions under Named Patient Program (NPP). Medvitaz provides patients and physicians access to commercially approved medicines that are not available to them in their own country. Medvitaz objectives is to make quality medicines available at affordable prices for patients and physicians. To get best retail price/cost of crizanlizumab-tmca injection in India, Call 8750295029 or Email urgent@medvitaz.com. FDA approved drugs of Australia, Canada, Delhi, EU, India, New Zealand, Singapore, Switzerland, Turkey & USA.

neeraj
Neeraj Nagpal

Head of Operations

 The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.

Contact Our Team

Contact us and we will reply as soon as possible!

    need help?

     MEDVITAZ is an initiative for helping end-users directly to get the right medicines and right medical treatments from the right source.